Monopar Therapeutics Inc. · NASDAQ:MNPR
Starr Christopher M sold 8,400 Monopar Therapeutics Inc. shares (Form 4)
Traded Oct 1, 2026 · Filed Oct 5, 2026
On Oct 1, 2026, Starr Christopher M (Director) sold 8,400 Monopar Therapeutics Inc. shares at an average US$78.50 for US$659K under a trading plan, leaving 5,173 shares. Filed Oct 5, 2026 (Form 4).
- Sold
- 8,400 shares
- Price
- US$78.50 average (US$78.09 to US$79.67)
- Value
- US$659K
- Holding after
- 5,173 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Common Stock | Option exercise | 8,400 | US$0.01 | 13,573 | Direct |
| Oct 1, 2026 | Common Stock | Sale | 4,631 | US$78.09 | 8,942 | Direct |
| Oct 1, 2026 | Common Stock | Sale | 2,970 | US$78.82 | 5,972 | Direct |
| Oct 1, 2026 | Common Stock | Sale | 799 | US$79.67 | 5,173 | Direct |